Sector consensus Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.68 USD | +5.19% |
|
-1.52% | +44.64% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 34.83 | +53.59% | 6 | ||||||
| 680.7 | +19.38% | 23 | ||||||
| 272.94 | +14.78% | 18 | ||||||
| 207 | +7.72% | 21 | ||||||
| 415.64 | +29.05% | 27 | ||||||
| 265,216.27 | +39.59% | 24 | ||||||
| 267.77 | +21.26% | 18 | ||||||
| 581.83 | +0.61% | 12 | ||||||
| 183.75 | +11.01% | 16 | ||||||
| 72.6 | +5.83% | 14 | ||||||
| 228.5 | -2.61% | 14 | ||||||
| 69.73 | -3.2% | 11 | ||||||
| 138.56 | +27.71% | 6 | ||||||
| 130.53 | -2.81% | 12 | ||||||
| 37.73 | +4.78% | 11 | ||||||
| 90.8 | +70.42% | 20 | ||||||
| 127.18 | +18.85% | 22 | ||||||
| 44.07 | +6.32% | 14 | ||||||
| 133.31 | -3.85% | 13 | ||||||
| 610.05 | +98.23% | 19 | ||||||
| Average | 13,477.19 | +20.83% | 16 | ||||||
| Weighted average by Cap. | 23,216.62 | +18.94% | 19 |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
